SEGLU 2.4MG INJ

SEGLU 2.4MG INJ contains semaglutide, a GLP-1 receptor agonist used for weight management and blood sugar control. Each injection delivers 2.4mg of the active ingredient, designed for subcutaneous administration. This medication helps reduce appetite and supports metabolic health when combined with lifestyle modifications. Suitable for adults seeking effective weight loss support or improved glycemic control. Store as directed and use only under medical supervision. Consult your healthcare provider to determine if this treatment is appropriate for your individual health needs.